Organizations
Conferences
Info & Opinion
January 8, 2009
In the United States, more seasoned veterans in the clinical investigator world drop out. In rest-of-world, it’s the new P.I.’s who are more likely to leave industry-sponsored research.
A clarification to recent ClinPage coverage of Pfizer at DIA.
In countries outside the U.S., principal investigators who elect not to do any more trials are usually the nervous newbies. That’s not a shock. What is surprising is that here in the U.S., those leaving clinical research, never to return,…
After a complaint from Pfizer, we’ve updated a recent story about DIA. There’s a link to our first story at the bottom of this article. It’s clear ClinPage accurately quoted Andy Lee, Pfizer’s vice president of clinical study and data…